Medical Membrane Devices: Markets and Technologies
The global market for medical membrane devices should grow from $28.6 billion in 2018 to $36.5 billion by 2023 at a compound annual growth rate (CAGR) of 5.0% for the period of 2018-2023.
- 21 data tables and 18 additional tables
- Detailed overview and an in-depth analysis of the medical membrane device industry structure
- Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Information on the present and future strategies within the different medical membrane devices market including hemodialyzers, membrane oxygenators, intravenous infusion (IV) filters, blood microfilters, apheresis systems and membrane diagnostic devices
- Segmentation of the global medical membrane device technologies market by technology type, end use, application industry and geographical region
- Technological assessment of the use of medical membrane devices for cardiopulmonary treatments, renal diseases, parenteral administration and home-care diagnosis
- Discussion of the impact of device applications and trends, pricing considerations, research and development activities and environmental influences, along with the performance of the market in terms of setbacks and the needs
- A frame for membrane components of each sector in context with the market dynamics of the overall technology
- Coverage of the latest significant patents by type of device, by company and other categorizations
- Profiles of major companies in the field along with a competitive technology analysis including 3M, Abbott Laboratories, Baxter International Inc., LifeScan Inc. and Toray Industries Inc.
The scope of this report encompasses key market analysis, market drivers, market constraints and also competitive developments and trends in the market. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections and market shares. This report involves the medical membrane devices used in the medical device industry. This report mainly deals with the medical membrane devices market covering the total market, which includes hemodialyzers, membrane oxygenators, intravenous infusion (IV) infusion filters, blood microfilters and apheresis systems, and membrane diagnostic devices. The report also covers the use of medical membrane devices for cardiopulmonary treatments, renal diseases, parenteral administration and home care diagnosis. It also covers details regarding healthcare spending and the U.S. healthcare system.
Excluded from this report are membranes employed in other facets of medicine. These applications and devices include hollow fiber bioreactors employed in the production of monoclonal antibodies, recombinant proteins and drugs, nonseparating membranes used in drug-delivery systems, tissue scaffolding and synthetic skin. In addition, experimental artificial organs (e.g., liver, pancreas, implanted lung); apheresis filtration for stem cell recovery, virus filters and other cross-flow filters used in the production of pharmaceuticals; and blotting membranes (excluding their application in diagnostics) will not be considered in this report.
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Global revenue for medical membrane devices was valued at $25.2 billion in 2013 and $25.6 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 2.3% from 2015 through 2020; reach $26.3 billion by 2015 and $29.4 billion by 2020.
- An overview of the global markets and technologies for medical membrane devices.
- Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of CAGRs through 2020.
- Analysis of the relevant technical and economic drivers for the medical membrane device market by technology type.
- Information on the impact of device applications and trends, pricing considerations, research and development (R&D), and environmental influences.
- Evaluation of the industry structure.
- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
- A frame for membrane components of each sector in context with the market dynamics of the overall technology.
- Profiles of major companies in the field along with a competitive technology analysis.
The U.S. medical membrane device market was valued at $2.1 billion in 2010 and is expected to be nearly $2.2 billion by the end of 2011. This market is forecast to grow to $2.9 billion by 2016, a compound annual growth rate (CAGR) of 5%.
- The medical membrane device market, which includes dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $2 billion in 2009 and is expected to increase at a compound annual growth rate (CAGR) of 4.6% through 2014
- Sales of dialyzers and blood oxygenators and IV filters are primarily market-driven, while sales of blood/apheresis filters and diagnostic devices are principally technology-driven
- Sales of diagnostic devices continue to skyrocket. Applauded by managed care, a growing number of point-of-care (POC) and home tests are available for a host of new and existing applications.
The medical membrane device market, including dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $1.8 billion in 2007 and is increasing at a compound annual growth rate (CAGR) of 5.3% to reach $ 2.3 billion in 2012.
The combined worth of market-driven devices is about $623 million, rising at a compound annual growth rate of 3.6%. More than 235,000 U.S. kidney patients require dialysis on an ongoing basis to maintain renal function. Growth in the hemodialyzer market is driven by an increasing patient population, the phaseout of reusable dialyzers and the discovery that nonmembrane home dialysis may be applicable to a broader target audience
Technology driven products, such as blood/apheresis microfilters and diagnostic devices, have a combined value of $1.1 billion, with a 6.2% CAGR. Sales of these products for the most part, are spurred by improvements in design and materials, and by new applications.
The U.S. medical membrane device market is valued at $1.7 billion in 2001.
Increasing at an average annual growth rate (AAGR) of 7.1%, this market is expected to reach nearly $2.5 billion in 2006.
Sales of dialyzers and blood oxygenators, and increasingly leukofilters, are primarily market driven and are valued at $883 million in 2001 and growing at an AAGR 8.1%.
Sales of IV filters, blood/apheresis filters and diagnostic devices are principally technology driven and have a combined value of $859 million, with a 5.9% AAGR.
Sales of diagnostic devices have skyrocketed, driven by managed care, point-of-care and home tests for a host of applications.